Presentations

PCT’s leaders and experts are active speakers and panelists at industry events. Explore past presentations below.

WFIRM

June 7, 2017

Scale to Survive: The Future of Cell Therapy

Dr. Robert Preti, Chief Executive Officer and President, PCT

cropped-aut-website-homepage-banner-1240x400.png

May 30, 2017

Visualising the centralised commercial cell-based therapy bioprocessing facility of tomorrow

Brian Hampson, VP of Global Manufacturing Sciences and Technology, PCT

cell&geneexchange.png

May 22, 2017

Introductory Remarks

Dr. Robert Preti, Chief Executive Officer and President, PCT

terrapinn 2017.png

May 18, 2017

Leveraging What Cell Therapy Manufacturing Processes Share to Approach Optimal Cost of Goods

Dr. Thomas Heathman, Business Leader, Technology Development, Manufacturing Development & GTP Services, PCT

ARM ATS.png

April 27, 2017

Welcome Remarks

Dr. Robert Preti, Chief Executive Officer and President, PCT

ARM ATS.png

March 22, 2017

Welcome and State of the Industry Remarks

Dr. Robert Preti, Chief Executive Officer and President, PCT

IS-Bio-Tech-logo.png

March 7, 2017

Successful Manufacturing of CAR T-Cell Therapies: Challenges and Opportunities

Dr. Cenk Sumen, Senior Manager, Business Development, PCT

aabb.png

February 23, 2017

Apheresis Optimization in Gene and Immunotherapy Development in Non-Mobilized Patients and Donors

Dr. Sanjin Zvonic, Senior Director, Buissness Leader, Clinical and Commercial Manufacturing, PCT

MolecularMedTriCon2017.png

February 20, 2017

From Idea to Industry: A History of CAR T-Cells to Where We Are Today, and the Challenges of Commercialization

Dr. Cenk Sumen, Senior Manager, Business Development, PCT

phaciltiate2017.png

January 18, 2017

Automation: Addressing the Key Pain Points in Cell and Gene Manufacture

Brian Hampson, VP of Global Manufacturing Sciences and Technology, PCT

wafsf.png

November 21, 2016

Overview: Cell and Gene Therapy

Dr. Robert Preti, Chief Executive Officer and President, PCT

ARM EU Day 2016.jpg
 November 3, 2016

Fireside Chat: Immuno-oncology

Dr. Robert Preti, President, PCT

cell-therapy-bioprocessing-denim-light-10d60dad59d07e28a567d81fbee13782.png

October 6, 2016

Enabling the Cell Therapy Factory of the Future

Brian Hampson, VP of Global Manufacturing Sciences and Technology, PCT

Mesa_Logo2.png

October 6, 2016

Process Improvement and Accelerated CMC Development Workshop

Dr. Robert Preti, President, PCT

Mesa_Logo2.png

October 5, 2016

Welcome Remarks

Dr. Robert Preti, President, PCT

phacilitateleaderseuropeforumlogonodate.png

September 22, 2016

How are the world's modified T cell immunotherapy leaders gearing up for market in Europe?

Dr. Cenk Sumen, Manager, Technology & Business Development, PCT

phacilitateleaderseuropeforumlogonodate.png

September 21, 2016

Presenting a vision for the future industrialization of ATMPs in Europe

Dr. Cenk Sumen, Manager, Technology & Business Development, PCT

brm-2016.png

July 11, 2016

Building the Future: Advanced Therapies & Scalability

Dr. Robert Preti, President, PCT 

ISCT2016.jpg

May 27, 2016

A Case Study of the Establishing of Global Commercial Enterprise for Cell Therapy Manufacturing

George Goldberger, Vice President, Business Development, PCT

ISCT2016.jpg

May 27, 2016

Managing Challenges to Achieve Optimal Cost of Goods

Dr. Ian Gaudet, Director, Innovation & Engineering, PCT

ISCT2016.jpg

May 26, 2016

Innovation for Hire: Contract Development in Cell Therapy

Dr. Ian Gaudet, Innovation & Engineering, PCT

world-stem-cells-2016.png

May 18, 2016

Scale to Survive: The Future of Cell Therapy

Dr. Robert Preti, President, PCT

cell___gene_therapy_world_2016.jpg

January 25, 2016 

Patient-Specific Cell Therapy Factory of the Future - Can You Get There From Here?

Brian Hampson, Vice President, Global Manufacturing Sciences and Technology, PCT

cell___gene_therapy_world_2016.jpg

January 25, 2016 

What Does Commercialization Look Like?

Brian Hampson, Vice President, Global Manufacturing Sciences and Technology, PCT

IBC2015-1.png

October 1, 2015

What Can Automation Do for You and When – Strategic Considerations, Examples and Lessons Learned

Brian Hampson, Vice President, Global Manufacturing Sciences and Technology, PCT

IBC2015-1.png

October 1, 2015

Alignment with Commercialization

Dr. Robert Preti, President, PCT
Dr. Ann Daus, Vice President, Quality Assurance and Quality Control, PCT

IBC2015-1.png

September 30, 2015

Partnering with a CMO Along the Road to Commercial Cell Therapy Manufacturing

Dr. Robert Preti, President, PCT

ISCT_Europe_2015.png

September 24, 2015

How to Drive the Translation of Cellular Therapies for the Benefit of Patients

Dr. Robert Preti, President, PCT

ISCT2015_banner.png

May 29, 2015

The Lovo Cell Processing System: A Technology Overview and Data Review

Jacob Ceccarelli, Biotechnology Engineer, PCT

WSCRMC.png

May 20, 2015

Accelerating Time To Market: Development and manufacturing considerations for cell therapy product commercialization

George Goldberger, Vice President of Business Development, PCT

biopharmareporter.png

January 28, 2015

Strategy and Innovation for Cell Therapy Manufacturing - Creating a Roadmap to a Commercial Future

Brian Hampson, Vice President, Global Manufacturing Sciences and Technology

c_gt__full_agenda_09.png

January 26, 2015

How Unique is Cell Therapy Manufacturing?

Harry Lam, formerly Vice President, Manufacturing & Technical Development, PCT

c_gt__full_agenda_09.png

January 26, 2015

Manufacturing and Process Development: Regulatory Experts at Hand

Dr. Robert Preti, President, PCT

BioKorea.png

October 22, 2014

Building Deliverable Cell Therapeutics: A Methodical Approach to Manufacturing Development

Brian Hampson, VP of Global Manufacturing Sciences and Technology, PCT

Richard Grant, Director of Cell Therapy, Invetech

Robert Shaw, formerly VP of Commercial Development, PCT

BioKorea.png

May 29, 2014

State of the RM Industry in the US and Global

Dr. Robert Preti, President, PCT

BioKorea.png

May 29, 2014

Alliance’s Technology and Research Achievements

Dr. Robert Preti, President, PCT

wscrmc14.png

May 21, 2014

Understanding the Path to Bring Your Cell Therapy to Market

Dr. Robert Preti, President, PCT

logo-rmf.png

May 5, 2014

Product Development Towards Commercialization in Regenerative Medicine

 Dr. Robert Preti, President, PCT

logo-rmf.png

May 5, 2014

Product Development Towards Commercialization in Regenerative Medicine

Dr. Robert Preti, President, PCT

gtcbio.png

February 21, 2014

Emerging Technologies

 Dr. Robert Preti, President, PCT

gtcbio.png

February 20, 2014

Strategies for Commercialization

Dr. Robert Preti, President, PCT

Dr. Sanjin Zvonic, formerly Director of Technology & Business Development, PCT

ny_stem_cell_summit.png

February 18, 2014

Cutting Time to Market for Stem Cell Suppliers

Dr. Robert Preti, President, PCT

10th_annual_phacilitate_cell___gene_therapy_forum_1387894325.png

January 27, 2014

Cell & Gene Therapy Business

Dr. Robert Preti, President, PCT

10th_annual_phacilitate_cell___gene_therapy_forum_1387894325.png

January 27, 2014

Product Characterization Assays – What are They Good for?

Timothy Fong, formerly VP of Technology & Product Development

scmom13.png

October 15, 2013

Regulatory Challenges & Strategies for Regen Med Companies

Dr. Robert Preti, President, PCT

CMCWorkshop13.png

April 17, 2013

Advanced-Therapy Medicinal Products (ATMP)

Dr. Robert Preti, President, PCT